Dr. Atanas Atanasov, country manager at Angelini Bulgaria, explains the affiliate’s growth to become a top ten player in the Bulgarian industry and highlights the leadership position of its portfolio in each category based on a long-term promotion strategy and value-based quality.
Angelini started its internationalisation process ten years ago, focusing on more than ten small and medium size markets like Poland, Croatia and of course Bulgaria. While the growth figures of the Bulgarian market look good, the market remains very limited; why do you believe Bulgaria was chosen as one of those key markets and what is the interest of a company like Angelini to be present here?
"Since Angelini settled on the Bulgarian territory ten years ago, many strategies have been implemented to grow the affiliate’s footprint here. As a main strategic driver, we started to improve our portfolio focus developing both Rx and OTC recent and new corporate core products."
